申请人:ZENECA LIMITED
公开号:EP0581464A1
公开(公告)日:1994-02-02
The invention concerns ester derivatives of the formula I
wherein Ar is phenyl, naphthyl, indenyl, indanyl, a 10-membered bicyclic heterocyclic moiety containing one or two nitrogen heteroatoms and optionally containing a further heteroatom selected from nitrogen, oxygen and sulphur, or a 9-membered or 10-membered bicyclic heterocyclic moiety containing one heteroatom group selected from oxygen, sulphur, sulphinyl, sulphonyl and imino;
A1 is a direct link to the oxygen atom of the ester group or A1 is (1-3C)alkylene ;
each of R4 and R5 is hydrogen or (1-4C)alkyl;
R1 is (1-4C)alkyl, (3-4C)alkenyl or (3-4C)alkynyl ; and
R2 and R3 together form a group of the formula -A2-X-A3- wherein each of A2 and A3 is independently (1-3C)alkylene and X is oxy, thio, sulphinyl, sulphonyl or imino;
or pharmaceutically-acceptable salts thereof ;
processes for their manufacture; pharmaceutical compositions containing them and their use as 5-lipoxygenase inhibitors.
该发明涉及以下式I的酯衍生物,其中Ar是苯基、萘基、茚基、茚基、含有一个或两个氮杂原子并且可选择地含有从氮、氧和硫中选择的进一步杂原子的一个含有10个成员的双环杂环基,或者含有从氧、硫、亚硫基、磺酰基和亚胺中选择的一个杂原子基团的9-成员或10-成员双环杂环基;A1是直接连接到酯基的氧原子的链或A1是(1-3C)烷基;R4和R5中的每一个是氢或(1-4C)烷基;R1是(1-4C)烷基、(3-4C)烯基或(3-4C)炔基;以及R2和R3共同形成下述式的一个基团-A2-X-A3-,其中A2和A3中的每一个独立地是(1-3C)烷基,X是氧、硫、亚硫基、磺酰基或亚胺;或其药学上可接受的盐;其制备方法;含有它们的药物组合物以及它们作为5-脂氧合酶抑制剂的用途。